Navigation Links
GNS Healthcare Collaborates with NCI in New Approach to Lung Cancer; Supercomputer Analysis to Aid in Matching Targeted Drugs to Patients
Date:8/13/2011

CAMBRIDGE, Mass., July 12, 2011 /PRNewswire/ -- GNS Healthcare, Inc. (GNS) is collaborating with the National Cancer Institute (NCI) to accelerate lung cancer research with a supercomputing platform that can rapidly uncover cause-and-effect mechanisms hidden in huge data sets assembled from imaging, genetics, pathology, and other areas. The results could help predict which patients will respond to a given treatment.

GNS will analyze NCI data from the laboratory of Terry van Dyke, Ph.D., Director of the Center for Advanced Preclinical Research (CAPR) at NCI. These data were generated from genetically modified mouse models of non-small cell lung cancer (NSCLC).

This collaboration will utilize GNS's supercomputer-driven REFS(TM) platform to build computer models of NSCLC in a hypothesis-free, unbiased manner that will be simulated to identify key molecular mechanisms of NSCLC.  The goal is to identify biomarkers and biological mechanisms that will lead to better matching of drugs to patients and new effective drugs in NSCLC.

"GNS is excited to be deploying our supercomputer-driven REFS(TM) platform to enable the maximal extraction of actionable knowledge from the rich lung cancer datasets generated by the NCI," said GNS Executive Vice President and Co-Founder Dr. Iya Khalil. "Combined with the expertise of our NCI colleagues in lung cancer biology and in designing powerful experiments to uncover its key mechanisms, we are creating the opportunity to provide better outcomes for lung cancer patients."

The data utilized in the collaboration will include data from the experimental assessment of transcriptomic and MRI data relating to NSCLC induction, regression and combination drug treatments.  Starting from this data, GNS will utilize the REFS(TM) platform to reverse-engineer network models from the data that connect drug doses to transcriptional and imaging measurement networks to endpoi
'/>"/>

SOURCE GNS Healthcare, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. GE Healthcare studies report results of [18F]Flutemetamol research
2. GNS Healthcare Collaborates with NCI in New Approach to Lung Cancer; Supercomputer Analysis to Aid in Matching Targeted Drugs to Patients
3. New Healthcare Franchise Opportunity Focuses on Treating Exploding Senior Population
4. Corning, GE Healthcare to receive Technical Achievement Award from Ceramic Society
5. Lexicon to Present Clinical Data for Diabetes Drug Candidate, LX4211, at Two Major Healthcare Conferences
6. Inventor honored for tech improving access to clean water, healthcare, and business development in India
7. The Full Yield, Inc. Launches Breakthrough Collaboration to Put Food Back at the Heart of Healthcare
8. TGen-Scottsdale Healthcare researchers make breakthrough in lung cancer
9. GE Healthcare to evaluate and develop novel imaging technology
10. Scott & White Healthcare researcher finds success with new anti-cancer drug
11. Scott & White Healthcare researcher finds success with new anti-cancer drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2015)... 26, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... http://www.nxt-id.com/ ) as part of its 2015 marketing and ... launched its new consumer website for Wocketwallet.com earlier this ... of NXT-ID said, "Our new corporate website naturally showcases ...
(Date:2/5/2015)... FRANCISCO , January 28, 2015 ... Market Analysis, Size And Segment Forecasts To 2020 has ... global IR camera market is expected to reach USD ... by Grand View Research, Inc. IR cameras help identify ... and are expected to witness surging demand in medical ...
(Date:2/5/2015)... DUBLIN , Jan. 28, 2015 Research ... announced the addition of the "Global Biometrics ... Use, Regions and Countries " report to their ... market, Asia-Pacific is anticipated ... by 2015, owing to increasing government spending towards ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3
... hypoxia in Green Bay, part of Lake Michigan, Wisc., have ... four-year $1,367,300 project through NOAA,s Coastal Hypoxia Research Program. Hypoxia ... recent evidence suggests that it may be worsening, with the ... more frequent and more extensive with a changing climate. ...
... Edinburgh, shows that sugary drinks, consumed in moderate quantities, ... mood effects in overweight women when they do not ... ,Effects of sucrose drinks on macronutrient intake, body weight, ... which was conducted by Marie Reid, Richard Hammersley and ...
... RICHLAND, Wash. -- As much as 12 percent of the ... producing biochar, a charcoal-like substance made from plants and other ... the same plants and materials were burned to generate energy, ... Communications ., These calculations show that biochar can play a ...
Cached Biology News:NOAA awards grant to investigate impacts of land use and climate change on hypoxia in Green Bay 2Research shows sugary drinks do not cause weight gain 2Charcoal takes some heat off global warming 2Charcoal takes some heat off global warming 3Charcoal takes some heat off global warming 4Charcoal takes some heat off global warming 5
(Date:3/4/2015)... Irvine, CA (PRWEB) March 04, 2015 ... research leader in Personalized Medicine, is excited to ... “Incorporating Genetic Testing to Optimize the Management of ... be available at Medscape.com for the next year. ... medical professionals how to recognize inadequate pain treatments, ...
(Date:3/4/2015)... San Jose, California (PRWEB) March 04, 2015 ... Chain Reaction (PCR) represents one of the fastest growing ... among cell biologists in subcellular visualization is driving growth ... The need for deeper understanding of gene expressions will ... reagents market. Expanding applications in fields ranging from pharma, ...
(Date:3/3/2015)... March 3, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: ... and molecular diagnostics that target the underlying mechanisms of ... seventh-month period ended December 31, 2014. Effective ... end from May 31 to December 31. As a ... today are for the quarter and the seven months ...
(Date:3/3/2015)... Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced several new ... in North America , the Middle ... "Bidding activity in 2015 continues to be robust" said Derek ... for bidding in 2014, we are pleased to see the bidding ... organization,s renewed focus on select market segments where we can add ...
Breaking Biology Technology:Proove Biosciences Launches CME Accredited Program with Medscape 2Proove Biosciences Launches CME Accredited Program with Medscape 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12
... HOLX ), a diversified medical technologies company ... dedicated to,serving the healthcare needs of women, today ... operating results on Thursday, May 1, 2008 at,8:00 ... will host,a conference call on Thursday, May 1, ...
... Wednesday, May 7, 2008 TIME: ... HOST: ... conduct a telephone conference call and,simultaneous webcast on Wednesday, May 7 at 9:30 ... 31, 2008. A,question and answer session will follow., Webcast Instructions, To ...
... by Mid-2008, COLLEGEVILLE, Pa. and TARRYTOWN, ... division of Wyeth (NYSE: WYE ), ... today announced that the companies,have received a ... from the Committee for Medicinal Products,for Human ...
Cached Biology Technology:Hologic, Inc. to Release Second Quarter Fiscal 2008 Operating Results Thursday, May 1st Before Market Opens 2Kendle Invites You to Attend its First Quarter 2008 Earnings Conference Call and Webcast 2Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients 2Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients 3Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients 4Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients 5
... were designed for full-length gene cloning and ... identify the desired cDNA clone. The first ... "Master Plate," where each well contains plasmid ... positive well(s) by gel electrophoresis of the ...
... CEQ 8800 Genetic Analysis System, which processes ... This automated system adds a higher level of ... CEQ 8800, part of Beckman Coulters new GenomeLab ... link with the Biomek series liquid handers, for ...
... cDNA Library Panels were designed for full-length ... of PCRs to identify the desired cDNA ... in a 96-well "Master Plate," where each ... Having identified the positive well(s) by gel ...
... cDNA Library Panels were designed for full-length ... of PCRs to identify the desired cDNA ... in a 96-well "Master Plate," where each ... Having identified the positive well(s) by gel ...
Biology Products: